The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enoxaparin Sodium Injection Market Research Report 2025
Synopsis
The global Enoxaparin Sodium Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enoxaparin Sodium Injection include Sanofi, Fresenius Kabi, Rovi, Amphastar, Teva, Nanjing King-friend, Techdow (Hepalink), Sandoz and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium Injection.
Report Scope
The Enoxaparin Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enoxaparin Sodium Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Fresenius Kabi
Rovi
Amphastar
Teva
Nanjing King-friend
Techdow (Hepalink)
Sandoz
Apotex
Cipla
Taj Pharma
Hangzhou Jiuyuan Gene Engineering
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Suzhou Erye Pharmaceutical
Segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enoxaparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Enoxaparin Sodium Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enoxaparin Sodium Injection include Sanofi, Fresenius Kabi, Rovi, Amphastar, Teva, Nanjing King-friend, Techdow (Hepalink), Sandoz and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium Injection.
Report Scope
The Enoxaparin Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enoxaparin Sodium Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Fresenius Kabi
Rovi
Amphastar
Teva
Nanjing King-friend
Techdow (Hepalink)
Sandoz
Apotex
Cipla
Taj Pharma
Hangzhou Jiuyuan Gene Engineering
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Suzhou Erye Pharmaceutical
Segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enoxaparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Enoxaparin Sodium Injection Market Overview
1.1 Product Overview and Scope of Enoxaparin Sodium Injection
1.2 Enoxaparin Sodium Injection Segment by Type
1.2.1 Global Enoxaparin Sodium Injection Market Value Comparison by Type (2024-2030)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Enoxaparin Sodium Injection Segment by Application
1.3.1 Global Enoxaparin Sodium Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Enoxaparin Sodium Injection Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin Sodium Injection Revenue 2019-2030
1.4.2 Global Enoxaparin Sodium Injection Sales 2019-2030
1.4.3 Global Enoxaparin Sodium Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enoxaparin Sodium Injection Market Competition by Manufacturers
2.1 Global Enoxaparin Sodium Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enoxaparin Sodium Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enoxaparin Sodium Injection Average Price by Manufacturers (2019-2024)
2.4 Global Enoxaparin Sodium Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enoxaparin Sodium Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enoxaparin Sodium Injection, Product Type & Application
2.7 Enoxaparin Sodium Injection Market Competitive Situation and Trends
2.7.1 Enoxaparin Sodium Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enoxaparin Sodium Injection Players Market Share by Revenue
2.7.3 Global Enoxaparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enoxaparin Sodium Injection Retrospective Market Scenario by Region
3.1 Global Enoxaparin Sodium Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enoxaparin Sodium Injection Global Enoxaparin Sodium Injection Sales by Region: 2019-2030
3.2.1 Global Enoxaparin Sodium Injection Sales by Region: 2019-2024
3.2.2 Global Enoxaparin Sodium Injection Sales by Region: 2025-2030
3.3 Global Enoxaparin Sodium Injection Global Enoxaparin Sodium Injection Revenue by Region: 2019-2030
3.3.1 Global Enoxaparin Sodium Injection Revenue by Region: 2019-2024
3.3.2 Global Enoxaparin Sodium Injection Revenue by Region: 2025-2030
3.4 North America Enoxaparin Sodium Injection Market Facts & Figures by Country
3.4.1 North America Enoxaparin Sodium Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enoxaparin Sodium Injection Sales by Country (2019-2030)
3.4.3 North America Enoxaparin Sodium Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enoxaparin Sodium Injection Market Facts & Figures by Country
3.5.1 Europe Enoxaparin Sodium Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enoxaparin Sodium Injection Sales by Country (2019-2030)
3.5.3 Europe Enoxaparin Sodium Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enoxaparin Sodium Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Enoxaparin Sodium Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enoxaparin Sodium Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Enoxaparin Sodium Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enoxaparin Sodium Injection Market Facts & Figures by Country
3.7.1 Latin America Enoxaparin Sodium Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enoxaparin Sodium Injection Sales by Country (2019-2030)
3.7.3 Latin America Enoxaparin Sodium Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enoxaparin Sodium Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Enoxaparin Sodium Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enoxaparin Sodium Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enoxaparin Sodium Injection Sales by Type (2019-2030)
4.1.1 Global Enoxaparin Sodium Injection Sales by Type (2019-2024)
4.1.2 Global Enoxaparin Sodium Injection Sales by Type (2025-2030)
4.1.3 Global Enoxaparin Sodium Injection Sales Market Share by Type (2019-2030)
4.2 Global Enoxaparin Sodium Injection Revenue by Type (2019-2030)
4.2.1 Global Enoxaparin Sodium Injection Revenue by Type (2019-2024)
4.2.2 Global Enoxaparin Sodium Injection Revenue by Type (2025-2030)
4.2.3 Global Enoxaparin Sodium Injection Revenue Market Share by Type (2019-2030)
4.3 Global Enoxaparin Sodium Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enoxaparin Sodium Injection Sales by Application (2019-2030)
5.1.1 Global Enoxaparin Sodium Injection Sales by Application (2019-2024)
5.1.2 Global Enoxaparin Sodium Injection Sales by Application (2025-2030)
5.1.3 Global Enoxaparin Sodium Injection Sales Market Share by Application (2019-2030)
5.2 Global Enoxaparin Sodium Injection Revenue by Application (2019-2030)
5.2.1 Global Enoxaparin Sodium Injection Revenue by Application (2019-2024)
5.2.2 Global Enoxaparin Sodium Injection Revenue by Application (2025-2030)
5.2.3 Global Enoxaparin Sodium Injection Revenue Market Share by Application (2019-2030)
5.3 Global Enoxaparin Sodium Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Enoxaparin Sodium Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Rovi
6.3.1 Rovi Corporation Information
6.3.2 Rovi Description and Business Overview
6.3.3 Rovi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Rovi Enoxaparin Sodium Injection Product Portfolio
6.3.5 Rovi Recent Developments/Updates
6.4 Amphastar
6.4.1 Amphastar Corporation Information
6.4.2 Amphastar Description and Business Overview
6.4.3 Amphastar Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amphastar Enoxaparin Sodium Injection Product Portfolio
6.4.5 Amphastar Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Enoxaparin Sodium Injection Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Nanjing King-friend
6.6.1 Nanjing King-friend Corporation Information
6.6.2 Nanjing King-friend Description and Business Overview
6.6.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio
6.6.5 Nanjing King-friend Recent Developments/Updates
6.7 Techdow (Hepalink)
6.6.1 Techdow (Hepalink) Corporation Information
6.6.2 Techdow (Hepalink) Description and Business Overview
6.6.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio
6.7.5 Techdow (Hepalink) Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sandoz Enoxaparin Sodium Injection Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Apotex Enoxaparin Sodium Injection Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cipla Enoxaparin Sodium Injection Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Taj Pharma
6.11.1 Taj Pharma Corporation Information
6.11.2 Taj Pharma Enoxaparin Sodium Injection Description and Business Overview
6.11.3 Taj Pharma Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Taj Pharma Enoxaparin Sodium Injection Product Portfolio
6.11.5 Taj Pharma Recent Developments/Updates
6.12 Hangzhou Jiuyuan Gene Engineering
6.12.1 Hangzhou Jiuyuan Gene Engineering Corporation Information
6.12.2 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Description and Business Overview
6.12.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio
6.12.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
6.13 Chengdu Baiyu Pharmaceutical
6.13.1 Chengdu Baiyu Pharmaceutical Corporation Information
6.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Description and Business Overview
6.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
6.13.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
6.14 Hebei Changshan Biochemical Pharmaceutical
6.14.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
6.14.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Description and Business Overview
6.14.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
6.14.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.15 Changzhou Qianhong Bio-pharma
6.15.1 Changzhou Qianhong Bio-pharma Corporation Information
6.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Description and Business Overview
6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio
6.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.16 Beijing SL Pharmaceutical
6.16.1 Beijing SL Pharmaceutical Corporation Information
6.16.2 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Description and Business Overview
6.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
6.16.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.17 Suzhou Erye Pharmaceutical
6.17.1 Suzhou Erye Pharmaceutical Corporation Information
6.17.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Description and Business Overview
6.17.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
6.17.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enoxaparin Sodium Injection Industry Chain Analysis
7.2 Enoxaparin Sodium Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enoxaparin Sodium Injection Production Mode & Process
7.4 Enoxaparin Sodium Injection Sales and Marketing
7.4.1 Enoxaparin Sodium Injection Sales Channels
7.4.2 Enoxaparin Sodium Injection Distributors
7.5 Enoxaparin Sodium Injection Customers
8 Enoxaparin Sodium Injection Market Dynamics
8.1 Enoxaparin Sodium Injection Industry Trends
8.2 Enoxaparin Sodium Injection Market Drivers
8.3 Enoxaparin Sodium Injection Market Challenges
8.4 Enoxaparin Sodium Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Enoxaparin Sodium Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enoxaparin Sodium Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Enoxaparin Sodium Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enoxaparin Sodium Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Enoxaparin Sodium Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enoxaparin Sodium Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enoxaparin Sodium Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enoxaparin Sodium Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enoxaparin Sodium Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enoxaparin Sodium Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enoxaparin Sodium Injection, Product Type & Application
Table 12. Global Key Manufacturers of Enoxaparin Sodium Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enoxaparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enoxaparin Sodium Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enoxaparin Sodium Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Enoxaparin Sodium Injection Sales Market Share by Region (2019-2024)
Table 19. Global Enoxaparin Sodium Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Enoxaparin Sodium Injection Sales Market Share by Region (2025-2030)
Table 21. Global Enoxaparin Sodium Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Enoxaparin Sodium Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Enoxaparin Sodium Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enoxaparin Sodium Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Enoxaparin Sodium Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Enoxaparin Sodium Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enoxaparin Sodium Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enoxaparin Sodium Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enoxaparin Sodium Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Enoxaparin Sodium Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Enoxaparin Sodium Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enoxaparin Sodium Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enoxaparin Sodium Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enoxaparin Sodium Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Enoxaparin Sodium Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Enoxaparin Sodium Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enoxaparin Sodium Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enoxaparin Sodium Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enoxaparin Sodium Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Enoxaparin Sodium Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Enoxaparin Sodium Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enoxaparin Sodium Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Enoxaparin Sodium Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Enoxaparin Sodium Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Enoxaparin Sodium Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Enoxaparin Sodium Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Enoxaparin Sodium Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enoxaparin Sodium Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Enoxaparin Sodium Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Enoxaparin Sodium Injection Sales Market Share by Type (2019-2024)
Table 53. Global Enoxaparin Sodium Injection Sales Market Share by Type (2025-2030)
Table 54. Global Enoxaparin Sodium Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enoxaparin Sodium Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Enoxaparin Sodium Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Enoxaparin Sodium Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Enoxaparin Sodium Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Enoxaparin Sodium Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Enoxaparin Sodium Injection Sales Market Share by Application (2019-2024)
Table 63. Global Enoxaparin Sodium Injection Sales Market Share by Application (2025-2030)
Table 64. Global Enoxaparin Sodium Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enoxaparin Sodium Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Enoxaparin Sodium Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Enoxaparin Sodium Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Enoxaparin Sodium Injection Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Fresenius Kabi Corporation Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Fresenius Kabi Enoxaparin Sodium Injection Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. Rovi Corporation Information
Table 81. Rovi Description and Business Overview
Table 82. Rovi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Rovi Enoxaparin Sodium Injection Product
Table 84. Rovi Recent Developments/Updates
Table 85. Amphastar Corporation Information
Table 86. Amphastar Description and Business Overview
Table 87. Amphastar Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Amphastar Enoxaparin Sodium Injection Product
Table 89. Amphastar Recent Developments/Updates
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Teva Enoxaparin Sodium Injection Product
Table 94. Teva Recent Developments/Updates
Table 95. Nanjing King-friend Corporation Information
Table 96. Nanjing King-friend Description and Business Overview
Table 97. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Nanjing King-friend Enoxaparin Sodium Injection Product
Table 99. Nanjing King-friend Recent Developments/Updates
Table 100. Techdow (Hepalink) Corporation Information
Table 101. Techdow (Hepalink) Description and Business Overview
Table 102. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Techdow (Hepalink) Enoxaparin Sodium Injection Product
Table 104. Techdow (Hepalink) Recent Developments/Updates
Table 105. Sandoz Corporation Information
Table 106. Sandoz Description and Business Overview
Table 107. Sandoz Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sandoz Enoxaparin Sodium Injection Product
Table 109. Sandoz Recent Developments/Updates
Table 110. Apotex Corporation Information
Table 111. Apotex Description and Business Overview
Table 112. Apotex Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Apotex Enoxaparin Sodium Injection Product
Table 114. Apotex Recent Developments/Updates
Table 115. Cipla Corporation Information
Table 116. Cipla Description and Business Overview
Table 117. Cipla Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Cipla Enoxaparin Sodium Injection Product
Table 119. Cipla Recent Developments/Updates
Table 120. Taj Pharma Corporation Information
Table 121. Taj Pharma Description and Business Overview
Table 122. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Taj Pharma Enoxaparin Sodium Injection Product
Table 124. Taj Pharma Recent Developments/Updates
Table 125. Hangzhou Jiuyuan Gene Engineering Corporation Information
Table 126. Hangzhou Jiuyuan Gene Engineering Description and Business Overview
Table 127. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product
Table 129. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
Table 130. Chengdu Baiyu Pharmaceutical Corporation Information
Table 131. Chengdu Baiyu Pharmaceutical Description and Business Overview
Table 132. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product
Table 134. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
Table 135. Hebei Changshan Biochemical Pharmaceutical Corporation Information
Table 136. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 137. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product
Table 139. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 140. Changzhou Qianhong Bio-pharma Corporation Information
Table 141. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 142. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product
Table 144. Changzhou Qianhong Bio-pharma Recent Developments/Updates
Table 145. Beijing SL Pharmaceutical Corporation Information
Table 146. Beijing SL Pharmaceutical Description and Business Overview
Table 147. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product
Table 149. Beijing SL Pharmaceutical Recent Developments/Updates
Table 150. Suzhou Erye Pharmaceutical Corporation Information
Table 151. Suzhou Erye Pharmaceutical Description and Business Overview
Table 152. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product
Table 154. Suzhou Erye Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Enoxaparin Sodium Injection Distributors List
Table 158. Enoxaparin Sodium Injection Customers List
Table 159. Enoxaparin Sodium Injection Market Trends
Table 160. Enoxaparin Sodium Injection Market Drivers
Table 161. Enoxaparin Sodium Injection Market Challenges
Table 162. Enoxaparin Sodium Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enoxaparin Sodium Injection
Figure 2. Global Enoxaparin Sodium Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enoxaparin Sodium Injection Market Share by Type in 2023 & 2030
Figure 4. 20 mg/0.2mL Product Picture
Figure 5. 30 mg/0.3mL Product Picture
Figure 6. 40 mg/0.4mL Product Picture
Figure 7. 60 mg/0.6mL Product Picture
Figure 8. 80 mg/0.8mL Product Picture
Figure 9. 100 mg/1mL Product Picture
Figure 10. 120 mg/0.8mL Product Picture
Figure 11. 150 mg/1mL Product Picture
Figure 12. 300mg/3mL Product Picture
Figure 13. Global Enoxaparin Sodium Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 14. Global Enoxaparin Sodium Injection Market Share by Application in 2023 & 2030
Figure 15. Hospital
Figure 16. Clinic
Figure 17. Others
Figure 18. Global Enoxaparin Sodium Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Enoxaparin Sodium Injection Market Size (2019-2030) & (US$ Million)
Figure 20. Global Enoxaparin Sodium Injection Sales (2019-2030) & (K Units)
Figure 21. Global Enoxaparin Sodium Injection Average Price (US$/Unit) & (2019-2030)
Figure 22. Enoxaparin Sodium Injection Report Years Considered
Figure 23. Enoxaparin Sodium Injection Sales Share by Manufacturers in 2023
Figure 24. Global Enoxaparin Sodium Injection Revenue Share by Manufacturers in 2023
Figure 25. The Global 5 and 10 Largest Enoxaparin Sodium Injection Players: Market Share by Revenue in 2023
Figure 26. Enoxaparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 27. Global Enoxaparin Sodium Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 28. North America Enoxaparin Sodium Injection Sales Market Share by Country (2019-2030)
Figure 29. North America Enoxaparin Sodium Injection Revenue Market Share by Country (2019-2030)
Figure 30. United States Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Canada Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Europe Enoxaparin Sodium Injection Sales Market Share by Country (2019-2030)
Figure 33. Europe Enoxaparin Sodium Injection Revenue Market Share by Country (2019-2030)
Figure 34. Germany Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. France Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. U.K. Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Italy Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Russia Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Asia Pacific Enoxaparin Sodium Injection Sales Market Share by Region (2019-2030)
Figure 40. Asia Pacific Enoxaparin Sodium Injection Revenue Market Share by Region (2019-2030)
Figure 41. China Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Japan Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. South Korea Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. India Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Australia Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. China Taiwan Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Indonesia Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Thailand Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Malaysia Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Enoxaparin Sodium Injection Sales Market Share by Country (2019-2030)
Figure 51. Latin America Enoxaparin Sodium Injection Revenue Market Share by Country (2019-2030)
Figure 52. Mexico Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Argentina Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Middle East & Africa Enoxaparin Sodium Injection Sales Market Share by Country (2019-2030)
Figure 56. Middle East & Africa Enoxaparin Sodium Injection Revenue Market Share by Country (2019-2030)
Figure 57. Turkey Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. UAE Enoxaparin Sodium Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Global Sales Market Share of Enoxaparin Sodium Injection by Type (2019-2030)
Figure 61. Global Revenue Market Share of Enoxaparin Sodium Injection by Type (2019-2030)
Figure 62. Global Enoxaparin Sodium Injection Price (US$/Unit) by Type (2019-2030)
Figure 63. Global Sales Market Share of Enoxaparin Sodium Injection by Application (2019-2030)
Figure 64. Global Revenue Market Share of Enoxaparin Sodium Injection by Application (2019-2030)
Figure 65. Global Enoxaparin Sodium Injection Price (US$/Unit) by Application (2019-2030)
Figure 66. Enoxaparin Sodium Injection Value Chain
Figure 67. Enoxaparin Sodium Injection Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
